Scandinavian Journal of Immunology

Papers
(The median citation count of Scandinavian Journal of Immunology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management199
Pattern of human monocyte subpopulations in health and disease112
Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms75
T cell immunobiology and cytokine storm of COVID‐1973
The TNF/IL‐23/IL‐17 axis—Head‐to‐head trials comparing different biologics in psoriasis treatment57
An inflammation classification system using cytokine parameters54
Mechanism of fibrosis and stricture formation in Crohn's disease53
Advances in Neutralization Assays for SARS‐CoV‐241
Current knowledge on autoantigens and autoantibodies in psoriasis40
Can medicinal mushrooms have prophylactic or therapeutic effect against COVID‐19 and its pneumonic superinfection and complicating inflammation?37
Interactions between SARS coronavirus 2 papain‐like protease and immune system: A potential drug target for the treatment of COVID‐1930
SARS‐CoV‐2 infection‐induced immune responses: Friends or foes?30
The role of innate immunity and inflammation in Parkinson´s disease28
TLR10: Insights, controversies and potential utility as a therapeutic target27
Targeting regulatory T cells in anti‐PD‐1/PD‐L1 cancer immunotherapy27
The potential involvement of P2X7 receptor in COVID‐19 pathogenesis: A new therapeutic target?26
Cold‐inducible RNA‐binding protein (CIRP) in inflammatory diseases: Molecular insights of its associated signalling pathways25
Immunodeficiency in cartilage‐hair hypoplasia: Pathogenesis, clinical course and management24
Mucosal chemokine CXCL17: What is known and not known24
Serum levels of soluble programmed death‐1 (sPD‐1) and soluble programmed death ligand 1(sPD‐L1) in systemic lupus erythematosus: Association with activity and severity24
Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review24
COVID‐19: Risk Factors Associated with Infectivity and Severity23
Reviewing the importance of TLR‐NLRP3‐pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors23
Overview of anti‐BCMA CAR‐T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma23
The role of herpesvirus 6A and 6B in multiple sclerosis and epilepsy22
Natural killer cell–derived extracellular vesicles in cancer therapy21
The attentive focus on T cell‐mediated autoimmune pathogenesis of psoriasis, lichen planus and vitiligo20
High CD4‐to‐CD8 ratio identifies an at‐risk population susceptible to lethal COVID‐1920
B cell class switching in intestinal immunity in health and disease20
Immunomodulatory potential of flavonoids for the treatment of autoimmune diseases and tumour19
COVID‐19 immunopathology with emphasis on Th17 response and cell‐based immunomodulation therapy: Potential targets and challenges19
The role of Interleukin‐32 in autoimmunity19
Involvement of autophagy in MHC class I antigen presentation18
Behçet disease (BD) and BD‐like clinical phenotypes: NF‐κB pathway in mucosal ulcerating diseases18
Umbilical cord mesenchymal stem cells as well as their released exosomes suppress proliferation of activated PBMCs in multiple sclerosis18
Are superantigens the cause of cytokine storm and viral sepsis in severe COVID‐19? Observations and hypothesis18
COVID‐19 and maternal pre‐eclampsia: A synopsis17
COVID‐19 and hepatic involvement: The liver as a main actor of the pandemic novel16
Antibody combinations for optimized staining of macrophages in human lung tumours16
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease16
B cell helper T cells and type 1 diabetes15
Features and roles of T helper 22 cells in immunological diseases and malignancies15
Immune surveillance in glioblastoma: Role of the NKG2D system and novel cell‐based therapeutic approaches15
Protective roles for myeloid cells in neuroinflammation15
Barley beta‐Glucan and Zymosan induce Dectin‐1 and Toll‐like receptor 2 co‐localization and anti‐leishmanial immune response in Leishmania donovani‐infected BALB/c mice15
Dual roles of granzyme B14
IgG‐mediated suppression of antibody responses: Hiding or snatching epitopes?14
T follicular regulatory cells: Guardians of the germinal centre?14
Immunogenetics in systemic lupus erythematosus: Transitioning from genetic associations to cellular effects14
A review of the immune response stimulated by xenogenic tissue heart valves14
Genetic interaction between the non‐homologous end‐joining factors during B and T lymphocyte development: In vivo mouse models14
Preoperative TruCulture® whole blood cytokine response predicts post‐operative inflammation in pancreaticoduodenectomy patients—A pilot cohort study13
Immune checkpoint blockade and biomarkers of clinical response in non–small cell lung cancer13
Cellular metabolism dictates T cell effector function in health and disease13
Upregulated microRNA‐132 in T helper 17 cells activates hepatic stellate cells to promote hepatocellular carcinoma cell migration in vitro12
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab12
Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis12
The roles of small‐molecule inflammatory mediators in rheumatoid arthritis12
Adipose‐derived mesenchymal stromal cells suppress osteoclastogenesis and bone erosion in collagen‐induced arthritis12
Approaches to inducing antigen‐specific immune tolerance in allergy and autoimmunity: Focus on antigen‐presenting cells and extracellular vesicles12
Increased expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and MMP10, MMP23 in inflammatory bowel disease: Cross‐sectional study11
Consequences of maternal psychological stress during pregnancy for the risk of asthma in the offspring11
T cell immunoglobulin and mucin domain protein 3 inhibits glycolysis in RAW 264.7 macrophages through Hexokinase 211
Long‐term in vitro persistence of magnetic properties after magnetic bead‐based cell separation of T cells11
Expression of TOB/BTG family members in patients with inflammatory bowel disease11
B cell signalling pathways—New targets for precision medicine in chronic lymphocytic leukaemia11
Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases11
An increase in CD62Ldim neutrophils precedes the development of pulmonary embolisms in COVID‐19 patients10
Putative role of marginal zone B cells in pathophysiological processes10
Spectrum of Inborn errors of immunity in a cohort of 90 patients presenting with complications to BCG vaccination in India10
Adaptor proteins: Flexible and dynamic modulators of immune cell signalling10
The immunomodulatory potentials of interleukin‐27 in airway allergies10
Perforin, COVID‐19 and a possible pathogenic auto‐inflammatory feedback loop10
Mast cell density in metastatic renal cell carcinoma: Association with prognosis and tumour‐infiltrating lymphocytes10
Fungal recognition by mammalian fibrinogen‐related proteins9
Immunobiology and conflicting roles of the human CD161 receptor in T cells9
Early humoral defence: Contributing to confining COVID‐19 to conducting airways?9
Rational harm‐benefit assessments by age group are required for continued COVID‐19 vaccination9
Differential diagnosis of primary immunodeficiency in patients with BCGitis and BCGosis: A single‐centre study9
Toll‐like receptor‐2/7‐mediated T cell activation: An innate potential to augment CD8+ T cell cytokine production9
Diagnostic and therapeutic caveats in Griscelli syndrome9
Coronavirus infection: An immunologists' perspective9
Immunoglobulin G complexes without sialic acids enhance osteoclastogenesis but do not affect arthritis‐mediated bone loss9
Innate lymphoid cells in colorectal cancer9
Serum‐soluble PD‐L1 may be a potential diagnostic biomarker in sepsis9
IL‐6 alters migration capacity of CD4+Foxp3+ regulatory T cells in systemic lupus erythematosus8
The role of the cholinergic anti‐inflammatory pathway in autoimmune rheumatic diseases8
Correlation of myeloid‐derived suppressor cells with C‐reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID‐198
Profiling the pattern of human TRB/IGH‐CDR3 repertoire in liver transplantation patients via high‐throughput sequencing analysis8
Insights into the toll‐like receptors in sexually transmitted infections8
Prognostic value and predictive biomarkers of phenotypes of tumour‐associated macrophages in colorectal cancer8
Role of the antigen presentation process in the immunization mechanism of the genetic vaccines against COVID‐19 and the need for biodistribution evaluations8
Immunophenotypic and functional analysis of lymphocyte subsets in common variable immunodeficiency patients without monogenic defects8
Functional immune reconstitution early after allogeneic haematopoietic cell transplantation: A comparison of pre‐ and post‐transplantation cytokine responses in stimulated whole blood8
Macrophages and scavenger receptors in obesity‐associated non‐alcoholic liver fatty disease (NAFLD)8
The pathogenesis of cutaneous lupus erythematosus: The aberrant distribution and function of different cell types in skin lesions8
Gastrointestinal and renal complications in SARS‐CoV‐2‐infected patients: Role of immune system8
The historical postulate: Is it the basis, at the level of the system, for self‐nonself discrimination?7
Interleukin 4 deficiency limits the development of a lupus‐like disease in mice triggered by phospholipids in a non‐bilayer arrangement7
Association of reduced maternal sHLA‐G5 isoform levels and elevated TNF‐α/IL‐4 cytokine ratio with Recurrent Pregnancy Loss: A study on South Indian women7
Decreased neutrophil‐mediated bacterial killing in COVID‐19 patients7
T cell receptor therapy against melanoma—Immunotherapy for the future?7
Immune and stromal related genes in colon cancer: Analysis of tumour microenvironment based on the cancer genome atlas (TCGA) and gene expression omnibus (GEO) databases7
Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS‐CoV‐2 infection7
Disease mechanisms in Sjögren’s syndrome: What do we know?7
A review on the interactions between dendritic cells, filarial parasite and parasite‐derived molecules in regulating the host immune responses7
Bioinformatics analysis of gene expression profiles of Inclusion body myositis7
The role of cytokines in determining the Th1/Th2 phenotype of an immune response: Coherence of the T cell response and the Cytokine Implementation Hypothesis7
An explanation of the pathogenesis of several autoimmune diseases in immuno‐compromised individuals7
CX3CR1 might be a promising predictor of systemic lupus erythematosus patients with pulmonary fibrosis7
Aicardi–Goutières syndrome: A monogenic type I interferonopathy6
The cytokine storm—An appropriate, over‐reactive response to SARS‐CoV‐2 or the wrong immune pathway?6
Interferons and innate immune activation in autoimmune congenital heart block6
Microbial sensing by haematopoietic stem and progenitor cells: Vigilance against infections and immune education of myeloid cells6
Non‐tuberculous mycobacteria immunopathogenesis: Closer than they appear. a prime of innate immunity trade‐off and NTM ways into virulence6
Upregulation of the expression of Toll‐like receptor 9 in basophils in patients with allergic rhinitis: An enhanced expression by allergens6
The effect of BCG vaccine in the era of COVID‐19 pandemic6
The immune microenvironment in typical carcinoid lung tumour, a brief report of four cases6
Severe COVID‐19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils6
Gut tissue‐resident memory T cells in coeliac disease6
The neonatal Fc receptor in mucosal immune regulation6
Lipopolysaccharide‐responsive beige‐like anchor acts as a cAMP‐dependent protein kinase anchoring protein in B cells6
Physiological levels of 25‐hydroxyvitamin D3 induce a suppressive CD4+ T cell phenotype not reflected in the epigenetic landscape6
Zinc homeostasis in immunity and its association with preterm births6
Myeloid‐derived suppressor cells: Bridging the gap between inflammation and pancreatic adenocarcinoma6
Chrysin enhances antitumour immunity response through the IL‐12‐STAT4 signal pathway in the B16F10 melanoma mouse model6
Advances in CD2476
Saturated fatty acids activate the inflammatory signalling pathway in Schwann cells: Implication in sciatic nerve injury6
Can interruption/withdrawl of anti‐retroviral therapy provide personalized immunotherapy against HIV‐1?6
SJI 2020 special issue: A catalogue of Ovarian Cancer targets for CAR therapy6
IL‐16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity6
Partial albinism and immunodeficiency in patients with Hermansky‐Pudlak Type II: Introducing 2 novel mutations5
Regulation of thymic T regulatory cell differentiation by TECs in health and disease5
The blood protein hCAP‐18 in neutropenia: An 18‐month experience of a new ELISA for clinical use5
Cellular scars and local crosstalk in relapsing psoriasis: an example of a skin sticking disease5
Waiting in the wings: RUNX3 reveals hidden depths of immune regulation with potential implications for inflammatory bowel disease5
Novel vaccine design based on genomics data analysis: A review5
Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients5
HLA‐DR+ mucosal‐associated invariant T cells predict poor prognosis in patients with sepsis: A prospective observational study5
Summary and comparison of the perforin in teleosts and mammals: A review5
Severe congenital neutropenia due to G6PC3 deficiency: Case series of five patients and literature review5
IL‐6 is associated with expansion of myeloid‐derived suppressor cells and enhanced immunosuppression in pancreatic adenocarcinoma patients4
On T cell development, T cell signals, T cell specificity and sensitivity, and the autoimmunity facilitated by lymphopenia4
Amoxicillin does not affect the development of cow’s milk allergy in a Brown Norway rat model4
Prognostic effect of coexisting TP53 and ZFHX3 mutations in non‐small cell lung cancer patients treated with immune checkpoint inhibitors4
Clinical and prognostic significance of CD14 (+) HLA‐DR (−/low) myeloid‐derived suppressor cells in patients with hepatocellular carcinoma received transarterial radioembolization with Yttrium‐904
Positive selection of immune repertoires: A short further history4
T cell help in the autoreactive germinal center4
Distinct macrophage phenotypes and redox environment during the fin fold regenerative process in zebrafish4
Downregulation of SOCS gene expression can inhibit the formation of acute and persistent BDV infections4
Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID‐19 in chronic lymphocytic leukaemia?4
Comments on the Discussion Forum: Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS‐CoV‐2 infection4
Exploring the role of the multiple sclerosis susceptibility gene CLEC16A in T cells4
Clinical, immunological and molecular findings of patients with DOCK‐8 deficiency from India4
Keratinocytes secrete multiple inflammatory and immune biomarkers, which are regulated by LL‐37, in a psoriasis mimicking microenvironment4
Paths taken towards NK cell–mediated immunotherapy of human cancer—a personal reflection4
A brief history of Scandinavian society for immunology4
XMEN saved by magnesium4
A proposed treatment for pathogenic enveloped viruses having high rates of mutation or replication4
Improved immunologic response to COVID‐19 vaccine with prolonged dosing interval in haemodialysis patients4
Novel immunosuppressive effect of FK506 by upregulation of PD‐L1 via FKBP51 in heart transplantation4
Metabolic optimization of adoptive T cell transfer cancer immunotherapy: A historical overview4
What will studies of Fulani individuals naturally exposed to malaria teach us about protective immunity to malaria?4
Missense (p.Glu778Lys) and (p.Gly908Arg) variants of NOD2 gene are associated with recurrent pulmonary non‐tuberculous mycobacterial infections4
T cell fate mapping and lineage tracing technologies probing clonal aspects underlying the generation of CD8 T cell subsets4
Physiology and pathology of eosinophils: Recent developments4
Single‐cell RNA sequencing distinguishes dendritic cell subsets in the rat, allowing advanced characterization of the effects of FMS‐like tyrosine kinase 3 ligand3
Monitoring disease activity in antineutrophil antibody‐associated vasculitis3
Polysaccharides and glycolipids of Mycobacterium tuberculosis and their induced immune responses3
Human macrophage C‐type lectin forms a heteromeric receptor complex with Mincle but not Dectin‐23
Long non‐coding RNAs in systemic lupus erythematosus: New insights into disease pathogenesis and diagnosis3
New era of therapy for endocrine autoimmune disorders3
C‐type lectin‐like CD161 is not a co‐signalling receptor in gluten‐reactive CD4 + T cells3
γ‐Secretase inhibitors suppress IL‐20‐mediated osteoclastogenesis via Notch signalling and are affected by Notch2 in vitro3
Comparison of current methods for anti‐dsDNA antibody detection and reshaping diagnostic strategies3
The adaptation model of immunity: Is the goal of central tolerance to eliminate defective T cells or self‐reactive T cells?3
Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls3
Interferon: The invisible link in the physiopathology of COVID‐19 and BCGitis?3
The prospect of targeting T cell immunoglobulin and mucin‐domain containing‐3 in renal cell carcinoma immunotherapy3
Human CD4+ and CD8+ T lymphocyte subpopulations have significantly different surface expression patterns of CD226 and TIGIT molecules3
Simultaneous neutralization of TGF‐β and IL‐6 attenuates Staphylococcus aureus‐induced arthritic inflammation through differential modulation of splenic and synovial macro3
Macrophage efferocytosis in atherosclerosis3
Analysis of SARS‐CoV‐2 haplotypes and genomic sequences during 2020 in Victoria, Australia, in the context of putative deficits in innate immune deaminase anti‐viral responses3
Roles of immune responses in the pathogenesis of immunorelated pancytopenia3
Clinical relevance of major histocompatibility complex class I chain–related molecule A (MICA) antibodies in live donor renal transplantation – Indian Experience3
An integrated view of immunological tolerance3
A pilot study towards the immunological effects of omalizumab treatment used to facilitate oral immunotherapy in peanut‐allergic adolescents3
Proteinase 3 Autoreactivity in Anti‐Neutrophil Cytoplasmic Antibody–associated vasculitis—Immunological versus clinical features3
The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes3
Comparative analysis of three methods in anti‐dsDNA antibodies detection: implications for Systemic Lupus Erythematosus diagnosis3
Cytarabine‐induced TNFα promotes the expansion and suppressive functions of myeloid‐derived suppressor cells in acute myeloid leukaemia3
Latent M. tuberculosis infection is associated with increased inflammatory cytokine and decreased suppressor of cytokine signalling (SOCS)‐3 in the diabetic host3
The prevalence of HPA‐1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR‐DQ haplotypes2
Exploring the role of basophil activation test in diagnosis of Dermatophagoides farinae sensitization and evaluation of therapeutic efficacy of subcutaneous immunotherapy in children2
Monoclonal antibody therapy that targets phospholipid‐binding protein delays lupus activity in MRL/lpr mice2
The diagnostic and prognostic significance of flow cytometric bone marrow assessment in myelodysplastic syndromes according to the European LeukemiaNet recommendations in single‐centre real‐life exper2
Single‐cell Raman trapping analysis revealed immunometabolism changes in peritoneal fluid in endometriosis2
Beginnings of coinhibition2
Potential role of AIM2 inflammasome in SARS‐CoV‐2 infection2
Pathogenic NKT cells attenuate urogenital chlamydial clearance and enhance infertility2
Stem‐cell transplantation for children with primary immune deficiencies: A retrospective study of 19 patients from one centre in Mexico2
Exosomes: Potential executors of IL‐35 gene‐modified adipose‐derived mesenchymal stem cells in inhibiting acute rejection after heart transplantation2
HLA‐DR covers Bare Lymphocyte Syndrome2
Increased proportions of inflammatory T cells and their correlations with cytokines and clinical parameters in patients with ankylosing spondylitis from northern Sweden2
Combination therapy with human amniotic epithelial cells and hyaluronic acid promotes immune balance recovery in type 1 diabetic rats through local engraftment2
IgM, IgA and IgG response to conjugate polysaccharides in children with recurrent respiratory infections2
Immune response against viral infections and nucleic acid‐based vaccines2
Flagellin induces innate immune genes in bronchial epithelial cells in vivo: Role of TET22
Galectin‐3 interacts with PD‐1 and counteracts the PD‐1 pathway‐driven regulation of T cell and osteoclast activity in Rheumatoid Arthritis2
The prospects of single‐cell analysis in autoimmunity2
The use of aluminium hydroxide as adjuvant modulates the specific antibody response—A Brown Norway rat study with native and denatured cow's milk allergens2
Decreased levels of T follicular helper (CD4+CXCR5+) cells and CD27+CD38+ and CD27+CD38− B cells in ankylosing spondylitis patients co2
Human natural killer cells in major histocompatibility complex class I deficiency2
Research progress of PD‐L1 non‐glycosylation in cancer immunotherapy2
Resolution of Th/Tc17‐driven inflammation during anti‐TNFα treatment of rheumatoid arthritis reveals a unique immune biomarker profiling pattern2
Abnormal expression of autophagy‐related proteins in immune thrombocytopenia2
Effects of intrauterine exposure to maternal‐derived HBeAg on T cell immunity in cord blood2
Prognostic significance of CKS2 and CD47 expression in patients with gastric cancer who underwent radical gastrectomy1
SARS‐CoV‐2 and Trojan horse phenomenon–caveat in vaccine quest?1
Withdrawal: Associations of tumor necrosis factor‐α polymorphisms with the risk of tuberculosis: a meta‐analysis1
Role of toll‐like receptors in the pathogenesis of COVID‐19: Current and future perspectives1
Jacob B. Natvig (1934‐2021), one of the founders of Scandinavian Journal of Immunology1
Human leptospirosis: In search for a better vaccine1
Risk assessment of human cytomegalovirus infection in solid organ transplantation: Insight into CD4+ T cell subsets1
The historical postulate is not the basis of self‐nonself discrimination: A response to Bretscher's proposal1
The adaptation model of immunity: A new insight into aetiology and treatment of multiple sclerosis1
Identification and characterization of murine glycoprotein 2‐expressing intestinal dendritic cells1
Virus‐infected mast cells activate virus‐specific CD8+ T cells1
Imbalanced distribution of group 2 innate lymphoid cells (ILCs) and ILC precursors in peripheral blood of patients with primary biliary cholangitis1
Impact of C1q fixing donor‐specific antibodies on renal transplant outcome1
No indication of aberrant neutrophil extracellular trap release in indolent or advanced systemic mastocytosis1
Activation of neutrophils excels the therapeutic potential of Mycobacterium indicus pranii and heat‐induced promastigotes against antimony‐resistant Leishmania donovani infection1
Pituitary neuropeptides and B lymphocyte function1
Relapsing/remitting multiple sclerosis: A speculative model and its implications for a novel treatment1
A novel DOCK2 variant in siblings with severe combined immunodeficiency1
Response to pneumococcal conjugate and polysaccharide vaccination in children with rheumatic disease1
Defending and integrating an organism by the immune system1
DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV‐19 vaccination and in normal unvaccinated blood donors1
Epstein‐Barr virus‐associated lymphocytic cholangitis in a child with X‐linked lymphoproliferative syndrome1
Effector memory T cell subset CD45RACCR7CD27CD28EM3 increases in direct proportion to the disease severity of COVI1
The prize of prizes: mRNA research paving the way for COVID‐19 vaccine success wins the Nobel Prize in Physiology or Medicine 20231
Immune checkpoint analysis of T‐cell responses to pp65 and IE‐1 antigens in end‐stage lung diseases1
Hyper‐IgM syndrome resulting from heterozygous AICDA variants: A European first?1
Clinical associations of serum Golgi apparatus antibodies in an immunology laboratory cohort1
Impact of monocyte‐related modulators and kidney function on mortality in hospitalized patients with COVID‐191
1
Method for high‐plex analysis of immune cells in human skin using the GeoMx system1
A single‐center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class‐ Switch Recombination defects1
SARS‐CoV‐2 (COVID‐19)‐specific T cell and B cell responses in convalescent rheumatoid arthritis: Monozygotic twins pair case observation1
PD‐1+CXCR5CD4+ T cells are correlated with the severity of lung adenocarcinoma malignant processes1
0.030287027359009